Tremfya achieved an impressions share of voice (SOV) of 3.35%, generating 2.1 billion total impressions. While the brand held ...
Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback